drug · small molecule
radiprodil
Phase 3updated 3mo agoby GRIN Therapeutics Inc🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
targets
Glutamate NMDA receptor; GRIN1/GRIN2B
all catalysts(0)
nothing on the calendar yet
Trials studying radiprodil
- phase3Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
- phase2Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
- phase1Phase 1 Open-Label Study of Radiprodil Pharmacokinetics, Safety, and Tolerability in Hepatically Impaired Participants
- phase1Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults
- phase1Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
- phase1Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 14m ago
Found something off?
comments(0)
5-min edit window · permanent after that